In the CAPOX-C arm , carriers of both @R and @F alleles had a statistically significant improvement in PFS ( @ years : @ % ; HR , @ ; P = @ ) and overall survival ( OS ; @ years : @ % ; HR , @ ; P = @ ) when compared with patients homozygous for @H and/or @V ( @-year PFS : @ % ; @-year OS : @ % ) .